Model A |
Model A |
Model A |
Model
A |
|
Individual center |
|
|
0.66 (0.56 - 0.78) |
<0.001 |
Model B |
Model B |
Model B |
Model
B |
|
Individual center |
|
|
0.68 (0.57 - 0.79) |
<0.001 |
Age |
0.98 (0.97 – 0.98) |
<0.001 |
|
|
Gender Female (Yes/No)
|
1.36 (1.24 – 1.50) |
<0.001 |
|
|
Transplant year |
0.95 (0.93 – 0.97) |
<0.001 |
|
|
Heart failure diagnosis |
Dilated as reference |
|
|
|
Ischemic Cardiomyopathy |
1.13 (1.02 – 1.25) |
0.01 |
|
|
Congenital |
1.01 (0.78 – 1.32) |
0.88 |
|
|
Restrictive |
1.04 (0.69 – 1.46) |
0.94 |
|
|
Hypertrophied |
0.91 (0.69 – 1.20) |
0.51 |
|
|
Valvular |
0.89 (0.69 – 1.14) |
0.37 |
|
|
African American (Yes/No) |
1.04 (0.94 – 1.16 |
0.40 |
|
|
PRA Class II >20% |
1.12 (0.90-1.40) |
0.29 |
|
|
HLA mismatch, 3 or more (Yes/No) |
1.23 (1.09 – 1.39) |
0.001 |
|
|
Donor:Recipient weight ratio |
0.80 (0.67 – 0.96) |
0.02 |
|
|
Donor age |
0.99 (0.99-1.01) |
0.20 |
|
|
Average transplant per year |
1.00 (0.99 – 1.01) |
0.80 |
|
|
Model C |
Model C |
Model C |
Model
C |
|
Individual center |
|
|
0.67 (0.57 - 0.79) |
<0.001 |
Age |
0.98 (0.97 – 0.98) |
<0.001 |
|
|
Gender Female (Yes/No)
|
1.36 (1.24 – 1.50) |
<0.001 |
|
|
Transplant year |
0.95 (0.93 – 0.97) |
<0.001 |
|
|
Heart failure diagnosis |
Dilated as reference |
|
|
|
Ischemic Cardiomyopathy |
1.13 (1.02 – 1.25) |
0.01 |
|
|
Congenital |
1.02 (0.78 – 1.32) |
0.87 |
|
|
Restrictive |
1.01 (0.70 – 1.48) |
0.91 |
|
|
Hypertrophied |
0.91 (0.69 – 1.20) |
0.53 |
|
|
Valvular |
0.89 (0.69 – 1.14) |
0.37 |
|
|
African American (Yes/No) |
1.04 (0.94 – 1.16 |
0.39 |
|
|
HLA mismatch, > 3 (Yes/No) |
1.23 (1.01 – 1.39) |
0.001 |
|
|
Donor:Recipient weight ratio |
0.79 (0.66 – 0.95) |
0.01 |
|
|
Average transplant per year |
1.00 (0.99 – 1.01) |
0.79 |
|
|
Induction Therapy |
0.93 (0.83 – 1.03) |
0.20 |
|
|